The Technology

Cancer Vaccine Produces 49% Melanoma Reduction in Patients Five Years Later

via Good News Network·Jun 8

A new vaccine combined with a drug has shown a 49% reduction in melanoma recurrence among patients after five years, marking a significant advancement in skin cancer treatment.

Read Full Story at Good News Network
ScienceHealth

Related Stories

Early Land Animals Skipped the Tadpole Phase, Fossil Study Finds

Ars Technica·17h ago

Chloroplast Study Reveals Molecular 'Lock' That Helps Power Life on Earth

Phys.org·17h ago

Butterflies That Live 25 Times Longer May Hold Clues to Healthy Human Aging

Smithsonian Magazine·17h ago

Archaeologists Find Rare 'Stonehenge Prototype' Aligned With the Solstices

Good News Network·17h ago
DiscussSoon
← Front Page